Figure 3From: Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population Analysis in patients with propensity score matching. RVR, EVR, ETR, and SVR rates were not statistically different between the two PEG-IFN groups in patients with genotype 1 (A) and genotype 2/3 (B).Back to article page